| |
|
|
| Name: |
Vestal Point Capital LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10012 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
86 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ACLX |
Arcellx, Inc. |
1 |
- |
$0.00 |
$156,634,000 |
2,387,720 |
11.19% |
120,206,000 |
1,912,720 |
4.441 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
2 |
- |
$33.16 |
$104,113,000 |
2,590,531 |
7.43% |
-6,431,000 |
240,531 |
1.887 |
Biotechnology |
|
|
INSM |
Insmed Inc |
3 |
- |
$99.49 |
$82,012,000 |
1,075,000 |
5.86% |
19,876,000 |
175,000 |
0.566 |
Biotechnology |
|
|
NUVL |
Nuvalent, Inc. |
4 |
- |
$0.00 |
$76,239,000 |
1,075,000 |
5.44% |
29,271,000 |
475,000 |
1.536 |
N/A |
|
|
VERA |
Vera Therapeutics, Inc. |
5 |
- |
$0.00 |
$60,050,000 |
2,500,000 |
4.29% |
14,588,000 |
1,425,000 |
4.56 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
6 |
- |
$11.41 |
$54,830,000 |
4,751,292 |
3.92% |
14,428,000 |
-18,708 |
9.069 |
N/A |
|
|
QURE |
uniQure B.V. |
7 |
- |
$13.86 |
$50,801,000 |
4,792,572 |
3.63% |
-2,621,000 |
1,767,572 |
10.77 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
8 |
- |
$29.96 |
$50,310,000 |
1,500,000 |
3.59% |
50,310,000 |
1,500,000 |
1.63 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
9 |
- |
$0.00 |
$43,615,000 |
1,300,000 |
3.11% |
11,863,000 |
490,000 |
1.727 |
N/A |
|
|
SRRK |
Scholar Rock Holding Corp |
10 |
New |
$35.81 |
$41,795,000 |
1,300,000 |
2.98% |
41,795,000 |
1,300,000 |
1.502 |
N/A |
|
|
BCAX |
Bicara Therapeutics Inc. |
11 |
- |
$8.71 |
$36,080,000 |
2,768,975 |
2.58% |
23,712,000 |
2,058,975 |
5.091 |
N/A |
|
|
GERN |
Geron Corporation |
12 |
- |
$1.49 |
$34,988,000 |
22,005,340 |
2.5% |
-3,952,000 |
11,005,340 |
4.052 |
Drug Manufacturers - ... |
|
|
FOLD |
Amicus Therapeutics Inc |
13 |
- |
$10.61 |
$34,884,000 |
4,275,000 |
2.49% |
3,327,000 |
925,000 |
1.257 |
Biotechnology |
|
|
IMTX |
Immatics N.V |
14 |
- |
$5.43 |
$32,439,000 |
7,192,700 |
2.32% |
-12,176,000 |
917,700 |
6.976 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
15 |
- |
$21.08 |
$30,967,000 |
1,788,990 |
2.21% |
-15,815,000 |
63,990 |
2.84 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
16 |
- |
$0.70 |
$30,839,000 |
1,700,069 |
2.2% |
7,404,000 |
625,069 |
5.231 |
N/A |
|
|
SVRA |
Savara Inc |
17 |
- |
$2.21 |
$30,470,000 |
11,000,000 |
2.18% |
-2,609,000 |
225,000 |
6.683 |
Biotechnology |
|
|
TYRA |
Tyra Biosciences, Inc. |
18 |
- |
$0.00 |
$26,782,000 |
2,879,829 |
1.91% |
13,021,000 |
1,889,829 |
5.46 |
N/A |
|
|
DHR |
Danaher Corp |
19 |
New |
$198.80 |
$25,625,000 |
125,000 |
1.83% |
25,625,000 |
125,000 |
0.018 |
General Building Mate... |
|
|
URGN |
Urogen Pharma Ltd. |
20 |
- |
$13.49 |
$23,812,000 |
2,152,957 |
1.7% |
6,452,000 |
522,957 |
5.113 |
N/A |
|
|
ASND |
Ascendis Pharma AS |
21 |
- |
$172.22 |
$23,401,000 |
150,142 |
1.67% |
-48,187,000 |
-369,858 |
0.232 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
22 |
- |
$5.57 |
$22,321,000 |
4,180,000 |
1.59% |
-15,048,000 |
0 |
7.055 |
N/A |
|
|
DAWN |
Day One Biopharmaceuticals,... |
23 |
- |
$0.00 |
$20,603,000 |
2,598,127 |
1.47% |
2,358,000 |
1,158,127 |
2.598 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
24 |
New |
$9.57 |
$18,828,000 |
1,800,000 |
1.34% |
18,828,000 |
1,800,000 |
1.56 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
25 |
- |
$36.52 |
$18,105,000 |
500,000 |
1.29% |
-45,000,000 |
-1,000,000 |
0.543 |
Restaurants |
|
|
LQDA |
Liquidia Technologies Inc |
26 |
- |
$13.10 |
$18,104,000 |
1,227,403 |
1.29% |
-2,594,000 |
-532,597 |
1.598 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
27 |
New |
$7.10 |
$17,970,000 |
3,000,000 |
1.28% |
17,970,000 |
3,000,000 |
2.3 |
N/A |
|
|
ESTA |
Establishment Labs Holdings... |
28 |
- |
$40.93 |
$17,676,000 |
433,193 |
1.26% |
3,855,000 |
133,193 |
1.55 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
29 |
- |
$0.00 |
$16,992,000 |
267,627 |
1.21% |
-5,996,000 |
-227,373 |
0.332 |
N/A |
|
|
PRGO |
Perrigo Co |
30 |
- |
$26.54 |
$16,478,000 |
587,649 |
1.18% |
6,837,000 |
212,649 |
0.431 |
Drug Related Products |
|
|
GEHC |
Ge Healthcare Holding Llc |
31 |
New |
$74.38 |
$16,475,000 |
204,130 |
1.18% |
16,475,000 |
204,130 |
0.045 |
N/A |
|
|
NYXH |
Nyxoah Ord Shs |
32 |
- |
$0.00 |
$16,186,000 |
2,318,954 |
1.16% |
-7,208,000 |
-605,262 |
9.076 |
N/A |
|
|
GMED |
Genomed Inc |
33 |
- |
$58.60 |
$14,640,000 |
200,000 |
1.05% |
-12,241,000 |
-125,000 |
0.173 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
34 |
- |
$0.00 |
$13,372,000 |
1,125,552 |
0.95% |
4,235,000 |
640,552 |
1.585 |
N/A |
|
|
SRPT |
Sarepta Therapeutics Inc |
35 |
- |
$17.11 |
$12,764,000 |
200,000 |
0.91% |
-17,634,000 |
-50,000 |
0.21 |
Drug Manufacturers - ... |
|
|
BRKR |
Bruker Corp |
36 |
- |
$41.80 |
$12,522,000 |
300,000 |
0.89% |
12,522,000 |
300,000 |
0.196 |
Scientific & Technica... |
|
|
CDTX |
Cidara Therapeutics, Inc. |
37 |
New |
$49.45 |
$10,868,000 |
504,542 |
0.78% |
10,868,000 |
504,542 |
11.062 |
N/A |
|
|
BDTX |
Black Diamond Therapeutics,... |
38 |
- |
$2.35 |
$8,680,000 |
5,600,000 |
0.62% |
-3,304,000 |
0 |
10.844 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
39 |
New |
$0.00 |
$7,814,000 |
200,000 |
0.56% |
7,814,000 |
200,000 |
0.318 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
40 |
- |
$4.72 |
$6,488,000 |
1,753,558 |
0.46% |
-4,912,000 |
-1,096,442 |
4.543 |
N/A |
|
|
IMVT |
Immunovant Inc |
41 |
- |
$0.00 |
$5,982,000 |
350,000 |
0.43% |
4,867,000 |
305,000 |
0.402 |
N/A |
|
|
ZYME |
Zymeworks Inc |
42 |
- |
$12.47 |
$5,955,000 |
500,000 |
0.43% |
3,247,000 |
315,000 |
0.714 |
N/A |
|
|
APLT |
Applied Therapeutics Inc. |
43 |
- |
$0.00 |
$5,622,000 |
11,500,000 |
0.4% |
-4,224,000 |
0 |
10.013 |
N/A |
|
|
ITOS |
Iteos Therapeutics, Inc. |
44 |
- |
$0.00 |
$5,373,000 |
900,000 |
0.38% |
-1,539,000 |
0 |
2.371 |
N/A |
|
|
GLPG |
Galapagos NV - ADR |
45 |
- |
$27.98 |
$5,024,000 |
200,000 |
0.36% |
74,000 |
20,000 |
0.306 |
N/A |
|
|
VYGR |
Voyager Therapeutics, Inc. |
46 |
- |
$2.96 |
$4,223,000 |
1,249,418 |
0.3% |
-2,751,000 |
19,418 |
3.334 |
N/A |
|
|
LXEO |
Lexeo Therapeutics, Inc. |
47 |
- |
$0.00 |
$3,943,000 |
1,136,249 |
0.28% |
-3,953,000 |
-63,751 |
0 |
N/A |
|
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
48 |
New |
$28.04 |
$3,773,000 |
169,864 |
0.27% |
3,773,000 |
169,864 |
0.42 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
49 |
- |
$20.29 |
$3,605,000 |
198,646 |
0.26% |
-4,102,000 |
-106,354 |
0.269 |
Diagnostic Substances |
|
|
OKUR |
OnKure Therapeutics, Inc. |
50 |
- |
$2.40 |
$2,731,000 |
635,000 |
0.2% |
-2,730,000 |
0 |
5.02 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
51 |
- |
$2.34 |
$2,300,000 |
2,000,000 |
0.16% |
-2,080,000 |
0 |
2.83 |
N/A |
|
|
ARCT |
Arcturus Therapeutics Ltd |
52 |
New |
$6.94 |
$2,243,000 |
211,790 |
0.16% |
2,243,000 |
211,790 |
0.793 |
N/A |
|
|
PASG |
Passage Bio, Inc. |
53 |
- |
$0.33 |
$2,154,000 |
6,100,000 |
0.15% |
-1,305,000 |
0 |
13.398 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
54 |
- |
$1.04 |
$1,988,000 |
2,515,850 |
0.14% |
-2,079,000 |
50,850 |
1.516 |
Biotechnology |
|
|
ANRO |
Alto Neuroscience, Inc. |
55 |
- |
$2.31 |
$1,976,000 |
915,000 |
0.14% |
-1,894,000 |
0 |
3.404 |
N/A |
|
|
STRO |
Sutro Biopharma Inc |
56 |
- |
$0.73 |
$1,692,000 |
2,600,000 |
0.12% |
-3,037,000 |
30,000 |
3.172 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
57 |
- |
$3.66 |
$1,658,000 |
370,000 |
0.12% |
-803,000 |
0 |
0.838 |
N/A |
|
|
ALEC |
Alector, Inc. |
58 |
New |
$1.48 |
$621,000 |
504,540 |
0.04% |
621,000 |
504,540 |
0.637 |
N/A |
|
|
ATRA |
Atara Biotherapeutics, Inc. |
59 |
- |
$7.96 |
$559,000 |
94,085 |
0.04% |
-1,105,000 |
-30,915 |
0.078 |
N/A |
|
|
TRAW |
Traws Pharma, Inc |
60 |
- |
$1.43 |
$403,000 |
175,000 |
0.03% |
-263,000 |
100,000 |
3.5 |
N/A |
|
|
MGNX |
Macrogenics Inc |
61 |
- |
$1.19 |
$356,000 |
280,000 |
0.03% |
-554,000 |
0 |
0.451 |
Biotechnology |
|
|
TENX |
Tenax Therapeutics Inc |
62 |
- |
$0.26 |
$350,000 |
53,439 |
0.02% |
8,000 |
-1,750 |
0.12 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
63 |
New |
$0.00 |
$214,000 |
14,888 |
0.02% |
214,000 |
14,888 |
0.011 |
N/A |
|
|
REGN |
Regeneron Pharmaceuticals Inc |
68 |
Closed |
$521.00 |
$0 |
0 |
0% |
-14,247,000 |
-20,000 |
0 |
Biotechnology |
|
|
ACHL |
Achilles Therapeutics Ameri... |
74 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,710,000 |
-1,500,000 |
0 |
N/A |
|
|
NGNE |
Neurogene |
80 |
Closed |
$3.68 |
$0 |
0 |
0% |
-1,829,000 |
-80,000 |
0 |
N/A |
|
|
TMDX |
Transmedics Group, Inc. |
67 |
Closed |
$131.45 |
$0 |
0 |
0% |
-3,118,000 |
-50,000 |
0 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
86 |
Closed |
$0.16 |
$0 |
0 |
0% |
-47,647,000 |
-1,060,000 |
0 |
N/A |
|
|
CMRX |
Chimerix Inc |
73 |
Closed |
$8.54 |
$0 |
0 |
0% |
-4,872,000 |
-1,400,000 |
0 |
Biotechnology |
|
|
LEGN |
Churchill Cap Corp Iii |
79 |
Closed |
$34.63 |
$0 |
0 |
0% |
-15,457,000 |
-475,000 |
0 |
N/A |
|
|
ZLAB |
Zai Lab Ltd |
66 |
Closed |
$34.74 |
$0 |
0 |
0% |
-7,857,000 |
-300,000 |
0 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
85 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,195,000 |
-1,500,000 |
0 |
N/A |
|
|
GSK |
GlaxoSmithKline Plc (ADR) |
72 |
Closed |
$40.41 |
$0 |
0 |
0% |
-33,820,000 |
-1,000,000 |
0 |
Drug Manufacturers - ... |
|
|
JAZZ |
Jazz Pharmaceuticals Inc |
78 |
Closed |
$109.27 |
$0 |
0 |
0% |
-120,071,000 |
-975,000 |
0 |
Biotechnology |
|
|
VERV |
Verve Therapeutics, Inc. |
65 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,638,000 |
-645,000 |
0 |
N/A |
|
|
ROIV |
Roivant Sciences Ltd. |
84 |
Closed |
$11.39 |
$0 |
0 |
0% |
-14,788,000 |
-1,250,000 |
0 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
71 |
Closed |
$9.56 |
$0 |
0 |
0% |
-6,122,000 |
-525,000 |
0 |
N/A |
|
|
AZN |
AstraZeneca Plc (ADR) |
77 |
Closed |
$69.85 |
$0 |
0 |
0% |
-31,122,000 |
-475,000 |
0 |
Drug Manufacturers - ... |
|
|
SNY |
Sanofi Aventis (ADR) |
64 |
Closed |
$47.85 |
$0 |
0 |
0% |
-36,173,000 |
-750,000 |
0 |
Drug Manufacturers - ... |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
83 |
Closed |
$300.75 |
$0 |
0 |
0% |
-29,314,000 |
-95,000 |
0 |
Diagnostic Substances |
|
|
BMRN |
Biomarin Pharmaceutical Inc |
70 |
Closed |
$88.63 |
$0 |
0 |
0% |
-56,528,000 |
-860,000 |
0 |
Drug Manufacturers - ... |
|
|
BHC |
Bausch Health Companies Inc |
76 |
Closed |
$6.46 |
$0 |
0 |
0% |
-2,015,000 |
-250,000 |
0 |
Biotechnology |
|
|
MRK |
Merck & Co Inc |
82 |
Closed |
$79.10 |
$0 |
0 |
0% |
-79,584,000 |
-800,000 |
0 |
Drug Manufacturers - ... |
|
|
IONS |
Ionis Pharmaceuticals Inc |
69 |
Closed |
$39.80 |
$0 |
0 |
0% |
-20,801,000 |
-595,000 |
0 |
Drug Manufacturers - ... |
|
|
A |
Agilent Technologies Inc |
75 |
Closed |
$119.17 |
$0 |
0 |
0% |
-10,076,000 |
-75,000 |
0 |
Scientific & Technica... |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
81 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,950,000 |
-425,000 |
0 |
N/A |
|
